Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Cash

by Monica Gerson, Benzinga Staff Writer

May 25, 2011 1:27 AM | 1 min read | Make a Comment

Below are the top small-cap diagnostic substances stocks on the NYSE and NASDAQ in terms of cash. Immucor Inc

BLUD

had $274.68 million in total cash and no debt for the latest quarter. AMAG Pharmaceuticals Inc

AMAG

had $238.23 million in total cash and no debt for the latest quarter. ABAXIS Inc

ABAX

had $69.45 million in total cash and $746.00 thousand in total debt for the latest quarter. Trinity Biotech plc

TRIB

had $59.82 million in total cash and $248.00 thousand in total debt for the latest quarter.

Posted In: Small Cap Analysis Markets Trading Ideas Diagnostic Substances Industry Health Care Health Care Equipment Health Care Supplies highest cash Life Sciences Tools & Services small-cap

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.